Light Therapy for Parkinson's Disease Symptoms

Light Therapy Intervention in Individuals With Parkinson's Disease

Recruiting N/A Interventional Study
Parkinson Disease
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
50 – 80
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
20 (estimated)
Sponsor
University of Delaware · Other
Who this trial is looking for

This trial is looking for people with Parkinson's disease to see how light therapy affects their symptoms. Participants will receive light therapy to the front of the head for 12 minutes, three times a week over six weeks.

Are You a Good Fit for This Trial?

You may be able to join if

  • I have been diagnosed with Parkinson's disease

You may not be able to join if

  • I cannot go off my Parkinson's medication for the assessments
  • I cannot provide consent
  • I have a Deep Brain Stimulation device
  • I have a history of a psychiatric disorder
  • I have other movement or neurological conditions like dementia or epilepsy
  • I have an atypical form of parkinsonism like progressive supranuclear palsy
  • I have a history of cancer
  • I have had a concussion or head injury in the last 6 months

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial
The study looks to investigate the effects that light therapy delivered to the frontal cortex could have on Parkinson's disease related symptoms ( both cognitive and motor). The therapy is a non invasive technique that deliverers low level wavelength light to the front part of the head for 12 minutes. for this study the therapy will be done 3 times a week for 6 weeks. To measure the potential effe…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Diagnosis of Parkinson disease Exclusion Criteria: 1. Participants who are unable to comply with study visit/testing requirements (e.g. participants who cannot go off PD medication for the pre-, post-, and 3-month assessments). 2. Participants who are unable to provide c…
Contacts

Sara Penuela, PhD student

9739740120

penuelas@udel.edu

CONTACT

Roxana Burciu, PhD, Associative Professor

rgburciu@udel.edu

CONTACT